http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108740356-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A40-70 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-223 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-142 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-223 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K50-80 |
| filingDate | 2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108740356-B |
| titleOfInvention | Use of lauroyl arginine ethyl ester derivatives as feed additives |
| abstract | The invention relates to a novel feed additive, in particular to the preparation of lauroyl arginine ethyl ester ion-pair compound derivatives by reacting lauroyl arginine ethyl ester LAE with an organic acid. Riemerella anatipestifer, which is caused by Riemerella anatipestifer, can treat peritonitis caused by Escherichia coli and Staphylococcus aureus, and can prevent and treat fish septicemia caused by Aeromonas mildew. LAE feed additives, its preventive and therapeutic effects have been significantly improved. The prepared lauroyl arginine ethyl ester derivative can be safely degraded in the human body and animal body, and the toxic and side effects are small, avoiding the generation of environmental resistant bacteria caused by the discharge of residual antibacterial agent into the environment, and achieving effective antibacterial effect. At the same time, the negative impact on the environment is small. |
| priorityDate | 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 174.